Johns Hopkins ABX Guide
Quinupristin + Dalfopristin
INDICATIONS
FDA
FDA
- Patients with serious or life-threatening infections associated with vancomycin-resistant Enterococcus faecium(VREF) bacteremia.
- Complicated skin and skin structure infections caused by Staphylococcus aureus (MSSA) or Streptococcus pyogenes.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Endocarditis (generally not recommended due to poorer clearance of bacteremia)
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: December 11, 2022
Citation
Auwaerter, Paul G, and Paul A Pham. "Quinupristin + Dalfopristin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2022. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540467/7/Quinupristin_+_Dalfopristin.
Auwaerter PG, Pham PA. Quinupristin + Dalfopristin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540467/7/Quinupristin_+_Dalfopristin. Accessed December 1, 2023.
Auwaerter, P. G., & Pham, P. A. (2022). Quinupristin + Dalfopristin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540467/7/Quinupristin_+_Dalfopristin
Auwaerter PG, Pham PA. Quinupristin + Dalfopristin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. [cited 2023 December 01]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540467/7/Quinupristin_+_Dalfopristin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Quinupristin + Dalfopristin
ID - 540467
A1 - Auwaerter,Paul,M.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2022/12/11/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540467/7/Quinupristin_+_Dalfopristin
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
